Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study.
Debess
Jeanne
J
Department of Oncology, Aalborg Hospital, Aarhus University, Aalborg, Denmark.
Riis
Jens Østergaard
JØ
Engebjerg
Malene Cramer
MC
Ewertz
Marianne
M
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D003071:Cognition / Q000187:drug effects*; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008137:Longitudinal Studies; D008875:Middle Aged; D009483:Neuropsychological Tests; D011788:Quality of Life; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects*; D013629:Tamoxifen / Q000009:adverse effects*
D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil